|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Marketing and sales | |||||
| General and administrative | |||||
| Amortization and impairment of intangibles | |||||
| Restructuring | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest and other income (expense), net | |||||
| Income before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Earnings per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Number of shares used in computation: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...